Loading…
Specific inhibitors of tyrosine-specific protein kinases: properties of 4-hydroxycinnamamide derivatives in vitro
Inhibition by seven synthetic 4-hydroxycinnamamide derivatives, ST 271, ST 280, ST 458, ST 494, ST 633, ST 638, and ST 642, of tyrosine-specific protein kinases (tyrosine kinase) of oncogene or proto-oncogene products (p130gag-v-fps, p70gag-actin-v-fgr, pp60v-src, pp60c-src) and epidermal growth fac...
Saved in:
Published in: | Cancer research (Chicago, Ill.) Ill.), 1989-05, Vol.49 (9), p.2374-2378 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | |
container_end_page | 2378 |
container_issue | 9 |
container_start_page | 2374 |
container_title | Cancer research (Chicago, Ill.) |
container_volume | 49 |
creator | SHIRAISHI, T OWADA, M. K TATSUKA, M YAMASHITA, T WATANABE, K KAKUNAGA, T |
description | Inhibition by seven synthetic 4-hydroxycinnamamide derivatives, ST 271, ST 280, ST 458, ST 494, ST 633, ST 638, and ST 642, of tyrosine-specific protein kinases (tyrosine kinase) of oncogene or proto-oncogene products (p130gag-v-fps, p70gag-actin-v-fgr, pp60v-src, pp60c-src) and epidermal growth factor (EGF) receptor kinase were investigated. ST 638 (alpha-cyano-3-ethoxy-4-hydroxy-5-phenylthiomethylcinnamamide) strongly inhibited more of the tyrosine kinases than any of the other compounds. The susceptibilities of these tyrosine kinases to ST 638 increased in the following order: EGF receptor greater than p70gag-actin-v-fgr greater than pp60c-src greater than p130gag-v-fps, pp60v-src, with 50% inhibitory concentration values of 1.1, 4.2, 18, 70, and 87 microM, respectively. The phosphorylation of the tyrosine residues in particulate fractions from RR1022 cells expressing pp60v-src was inhibited by ST 638 in a dose-dependent way, while it had a negligible effect on the phosphorylations of threonine and serine residues. Kinetic analysis showed that ST 638 competitively inhibited the phosphorylation of an exogenous substrate by the EGF receptor kinase with a Ki of 2.1 microM. ST 638 noncompetitively inhibited autophosphorylation by EGF receptor kinase. These results indicate that ST 638 is a potent and specific inhibitor of tyrosine kinases in vitro, and that its inhibitory activity is caused by competing with the substrate protein for the tyrosine kinase binding site. |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_76288944</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>15221071</sourcerecordid><originalsourceid>FETCH-LOGICAL-h214t-a92500bddbd81e910d6d0fc65a40be2e0ec6aba9a3e2a617ca79120ea1a482723</originalsourceid><addsrcrecordid>eNqFkE1LxDAQhoMo67r6E4QexFshSZOm9SaLXyB4UM9lmkzZ0X5t0l3sv7dq9eppmHmedxjmgC2FTrLYKKUP2ZJznsVaGXnMTkJ4m1otuF6whTQ8TaVesu1zj5YqshG1Gypp6HyIuioaRt8FajEOv7z33YDURu_UQsBw9TXo0Q-E3wEVb0bnu4_RUttCAw05jBx62sNA-8mZonsafHfKjiqoA57NdcVeb29e1vfx49Pdw_r6Md5IoYYYcqk5L50rXSYwF9yljlc21aB4iRI52hRKyCFBCakwFkwuJEcQoDJpZLJilz97pzu3OwxD0VCwWNfQYrcLhUllluVK_SsKLaXgRkzi-SzuygZd0XtqwI_F_MyJX8wcgoW68tBaCn-aSYRMjUo-AYNNgNo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>15221071</pqid></control><display><type>article</type><title>Specific inhibitors of tyrosine-specific protein kinases: properties of 4-hydroxycinnamamide derivatives in vitro</title><source>EZB Electronic Journals Library</source><creator>SHIRAISHI, T ; OWADA, M. K ; TATSUKA, M ; YAMASHITA, T ; WATANABE, K ; KAKUNAGA, T</creator><creatorcontrib>SHIRAISHI, T ; OWADA, M. K ; TATSUKA, M ; YAMASHITA, T ; WATANABE, K ; KAKUNAGA, T</creatorcontrib><description>Inhibition by seven synthetic 4-hydroxycinnamamide derivatives, ST 271, ST 280, ST 458, ST 494, ST 633, ST 638, and ST 642, of tyrosine-specific protein kinases (tyrosine kinase) of oncogene or proto-oncogene products (p130gag-v-fps, p70gag-actin-v-fgr, pp60v-src, pp60c-src) and epidermal growth factor (EGF) receptor kinase were investigated. ST 638 (alpha-cyano-3-ethoxy-4-hydroxy-5-phenylthiomethylcinnamamide) strongly inhibited more of the tyrosine kinases than any of the other compounds. The susceptibilities of these tyrosine kinases to ST 638 increased in the following order: EGF receptor greater than p70gag-actin-v-fgr greater than pp60c-src greater than p130gag-v-fps, pp60v-src, with 50% inhibitory concentration values of 1.1, 4.2, 18, 70, and 87 microM, respectively. The phosphorylation of the tyrosine residues in particulate fractions from RR1022 cells expressing pp60v-src was inhibited by ST 638 in a dose-dependent way, while it had a negligible effect on the phosphorylations of threonine and serine residues. Kinetic analysis showed that ST 638 competitively inhibited the phosphorylation of an exogenous substrate by the EGF receptor kinase with a Ki of 2.1 microM. ST 638 noncompetitively inhibited autophosphorylation by EGF receptor kinase. These results indicate that ST 638 is a potent and specific inhibitor of tyrosine kinases in vitro, and that its inhibitory activity is caused by competing with the substrate protein for the tyrosine kinase binding site.</description><identifier>ISSN: 0008-5472</identifier><identifier>EISSN: 1538-7445</identifier><identifier>PMID: 2706625</identifier><identifier>CODEN: CNREA8</identifier><language>eng</language><publisher>Philadelphia, PA: American Association for Cancer Research</publisher><subject>4-hydroxycinnamamide ; Adenosine Triphosphate - metabolism ; Analytical, structural and metabolic biochemistry ; Animals ; Binding, Competitive ; Biological and medical sciences ; Cinnamates - pharmacology ; Coumaric Acids - pharmacology ; Enzymes and enzyme inhibitors ; ErbB Receptors - metabolism ; Fundamental and applied biological sciences. Psychology ; Humans ; Kinetics ; oncogenes ; oncoproteins ; Phosphorylation ; Propionates ; Protein-Tyrosine Kinases - antagonists & inhibitors ; Transferases</subject><ispartof>Cancer research (Chicago, Ill.), 1989-05, Vol.49 (9), p.2374-2378</ispartof><rights>1989 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=7312674$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2706625$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>SHIRAISHI, T</creatorcontrib><creatorcontrib>OWADA, M. K</creatorcontrib><creatorcontrib>TATSUKA, M</creatorcontrib><creatorcontrib>YAMASHITA, T</creatorcontrib><creatorcontrib>WATANABE, K</creatorcontrib><creatorcontrib>KAKUNAGA, T</creatorcontrib><title>Specific inhibitors of tyrosine-specific protein kinases: properties of 4-hydroxycinnamamide derivatives in vitro</title><title>Cancer research (Chicago, Ill.)</title><addtitle>Cancer Res</addtitle><description>Inhibition by seven synthetic 4-hydroxycinnamamide derivatives, ST 271, ST 280, ST 458, ST 494, ST 633, ST 638, and ST 642, of tyrosine-specific protein kinases (tyrosine kinase) of oncogene or proto-oncogene products (p130gag-v-fps, p70gag-actin-v-fgr, pp60v-src, pp60c-src) and epidermal growth factor (EGF) receptor kinase were investigated. ST 638 (alpha-cyano-3-ethoxy-4-hydroxy-5-phenylthiomethylcinnamamide) strongly inhibited more of the tyrosine kinases than any of the other compounds. The susceptibilities of these tyrosine kinases to ST 638 increased in the following order: EGF receptor greater than p70gag-actin-v-fgr greater than pp60c-src greater than p130gag-v-fps, pp60v-src, with 50% inhibitory concentration values of 1.1, 4.2, 18, 70, and 87 microM, respectively. The phosphorylation of the tyrosine residues in particulate fractions from RR1022 cells expressing pp60v-src was inhibited by ST 638 in a dose-dependent way, while it had a negligible effect on the phosphorylations of threonine and serine residues. Kinetic analysis showed that ST 638 competitively inhibited the phosphorylation of an exogenous substrate by the EGF receptor kinase with a Ki of 2.1 microM. ST 638 noncompetitively inhibited autophosphorylation by EGF receptor kinase. These results indicate that ST 638 is a potent and specific inhibitor of tyrosine kinases in vitro, and that its inhibitory activity is caused by competing with the substrate protein for the tyrosine kinase binding site.</description><subject>4-hydroxycinnamamide</subject><subject>Adenosine Triphosphate - metabolism</subject><subject>Analytical, structural and metabolic biochemistry</subject><subject>Animals</subject><subject>Binding, Competitive</subject><subject>Biological and medical sciences</subject><subject>Cinnamates - pharmacology</subject><subject>Coumaric Acids - pharmacology</subject><subject>Enzymes and enzyme inhibitors</subject><subject>ErbB Receptors - metabolism</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Humans</subject><subject>Kinetics</subject><subject>oncogenes</subject><subject>oncoproteins</subject><subject>Phosphorylation</subject><subject>Propionates</subject><subject>Protein-Tyrosine Kinases - antagonists & inhibitors</subject><subject>Transferases</subject><issn>0008-5472</issn><issn>1538-7445</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1989</creationdate><recordtype>article</recordtype><recordid>eNqFkE1LxDAQhoMo67r6E4QexFshSZOm9SaLXyB4UM9lmkzZ0X5t0l3sv7dq9eppmHmedxjmgC2FTrLYKKUP2ZJznsVaGXnMTkJ4m1otuF6whTQ8TaVesu1zj5YqshG1Gypp6HyIuioaRt8FajEOv7z33YDURu_UQsBw9TXo0Q-E3wEVb0bnu4_RUttCAw05jBx62sNA-8mZonsafHfKjiqoA57NdcVeb29e1vfx49Pdw_r6Md5IoYYYcqk5L50rXSYwF9yljlc21aB4iRI52hRKyCFBCakwFkwuJEcQoDJpZLJilz97pzu3OwxD0VCwWNfQYrcLhUllluVK_SsKLaXgRkzi-SzuygZd0XtqwI_F_MyJX8wcgoW68tBaCn-aSYRMjUo-AYNNgNo</recordid><startdate>19890501</startdate><enddate>19890501</enddate><creator>SHIRAISHI, T</creator><creator>OWADA, M. K</creator><creator>TATSUKA, M</creator><creator>YAMASHITA, T</creator><creator>WATANABE, K</creator><creator>KAKUNAGA, T</creator><general>American Association for Cancer Research</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7QL</scope><scope>7TO</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>M81</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>19890501</creationdate><title>Specific inhibitors of tyrosine-specific protein kinases: properties of 4-hydroxycinnamamide derivatives in vitro</title><author>SHIRAISHI, T ; OWADA, M. K ; TATSUKA, M ; YAMASHITA, T ; WATANABE, K ; KAKUNAGA, T</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-h214t-a92500bddbd81e910d6d0fc65a40be2e0ec6aba9a3e2a617ca79120ea1a482723</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1989</creationdate><topic>4-hydroxycinnamamide</topic><topic>Adenosine Triphosphate - metabolism</topic><topic>Analytical, structural and metabolic biochemistry</topic><topic>Animals</topic><topic>Binding, Competitive</topic><topic>Biological and medical sciences</topic><topic>Cinnamates - pharmacology</topic><topic>Coumaric Acids - pharmacology</topic><topic>Enzymes and enzyme inhibitors</topic><topic>ErbB Receptors - metabolism</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Humans</topic><topic>Kinetics</topic><topic>oncogenes</topic><topic>oncoproteins</topic><topic>Phosphorylation</topic><topic>Propionates</topic><topic>Protein-Tyrosine Kinases - antagonists & inhibitors</topic><topic>Transferases</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>SHIRAISHI, T</creatorcontrib><creatorcontrib>OWADA, M. K</creatorcontrib><creatorcontrib>TATSUKA, M</creatorcontrib><creatorcontrib>YAMASHITA, T</creatorcontrib><creatorcontrib>WATANABE, K</creatorcontrib><creatorcontrib>KAKUNAGA, T</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Biochemistry Abstracts 3</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer research (Chicago, Ill.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>SHIRAISHI, T</au><au>OWADA, M. K</au><au>TATSUKA, M</au><au>YAMASHITA, T</au><au>WATANABE, K</au><au>KAKUNAGA, T</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Specific inhibitors of tyrosine-specific protein kinases: properties of 4-hydroxycinnamamide derivatives in vitro</atitle><jtitle>Cancer research (Chicago, Ill.)</jtitle><addtitle>Cancer Res</addtitle><date>1989-05-01</date><risdate>1989</risdate><volume>49</volume><issue>9</issue><spage>2374</spage><epage>2378</epage><pages>2374-2378</pages><issn>0008-5472</issn><eissn>1538-7445</eissn><coden>CNREA8</coden><abstract>Inhibition by seven synthetic 4-hydroxycinnamamide derivatives, ST 271, ST 280, ST 458, ST 494, ST 633, ST 638, and ST 642, of tyrosine-specific protein kinases (tyrosine kinase) of oncogene or proto-oncogene products (p130gag-v-fps, p70gag-actin-v-fgr, pp60v-src, pp60c-src) and epidermal growth factor (EGF) receptor kinase were investigated. ST 638 (alpha-cyano-3-ethoxy-4-hydroxy-5-phenylthiomethylcinnamamide) strongly inhibited more of the tyrosine kinases than any of the other compounds. The susceptibilities of these tyrosine kinases to ST 638 increased in the following order: EGF receptor greater than p70gag-actin-v-fgr greater than pp60c-src greater than p130gag-v-fps, pp60v-src, with 50% inhibitory concentration values of 1.1, 4.2, 18, 70, and 87 microM, respectively. The phosphorylation of the tyrosine residues in particulate fractions from RR1022 cells expressing pp60v-src was inhibited by ST 638 in a dose-dependent way, while it had a negligible effect on the phosphorylations of threonine and serine residues. Kinetic analysis showed that ST 638 competitively inhibited the phosphorylation of an exogenous substrate by the EGF receptor kinase with a Ki of 2.1 microM. ST 638 noncompetitively inhibited autophosphorylation by EGF receptor kinase. These results indicate that ST 638 is a potent and specific inhibitor of tyrosine kinases in vitro, and that its inhibitory activity is caused by competing with the substrate protein for the tyrosine kinase binding site.</abstract><cop>Philadelphia, PA</cop><pub>American Association for Cancer Research</pub><pmid>2706625</pmid><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0008-5472 |
ispartof | Cancer research (Chicago, Ill.), 1989-05, Vol.49 (9), p.2374-2378 |
issn | 0008-5472 1538-7445 |
language | eng |
recordid | cdi_proquest_miscellaneous_76288944 |
source | EZB Electronic Journals Library |
subjects | 4-hydroxycinnamamide Adenosine Triphosphate - metabolism Analytical, structural and metabolic biochemistry Animals Binding, Competitive Biological and medical sciences Cinnamates - pharmacology Coumaric Acids - pharmacology Enzymes and enzyme inhibitors ErbB Receptors - metabolism Fundamental and applied biological sciences. Psychology Humans Kinetics oncogenes oncoproteins Phosphorylation Propionates Protein-Tyrosine Kinases - antagonists & inhibitors Transferases |
title | Specific inhibitors of tyrosine-specific protein kinases: properties of 4-hydroxycinnamamide derivatives in vitro |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T10%3A31%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Specific%20inhibitors%20of%20tyrosine-specific%20protein%20kinases:%20properties%20of%204-hydroxycinnamamide%20derivatives%20in%20vitro&rft.jtitle=Cancer%20research%20(Chicago,%20Ill.)&rft.au=SHIRAISHI,%20T&rft.date=1989-05-01&rft.volume=49&rft.issue=9&rft.spage=2374&rft.epage=2378&rft.pages=2374-2378&rft.issn=0008-5472&rft.eissn=1538-7445&rft.coden=CNREA8&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E15221071%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-h214t-a92500bddbd81e910d6d0fc65a40be2e0ec6aba9a3e2a617ca79120ea1a482723%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=15221071&rft_id=info:pmid/2706625&rfr_iscdi=true |